Initial Public Offering.

A biotechnology company,

Keros Therapeutics,

completed its IPO on April 8,

2020,

and listed on the Nasdaq.

Keros

sold

6,000,000

shares of stock to primary market investors at an IPO offer price of

$16.91,

with an underwriting discount of

6.6%.

Secondary market investors, however, were paying

$20.12

per share for

Keros'

19,189,391

shares of stock outstanding (which includes the newly-issued

shares).

a. Calculate the total proceeds for

Keros'

IPO.

b. Calculate the dollar amount of the underwriting fee for

Keros'

IPO.

c. Calculate the net proceeds for

Keros'

IPO.

d. Calculate market capitalization for

Keros'

outstanding stock.

e. Calculate IPO underpricing for

Keros'

IPO.

f. Explain the IPO underpricing for

Keros.

Question content area bottom

Part 1

a. The total proceeds for

Keros'

IPO is

$enter your response here.

(Round to the nearestdollar.)